AxoGen, Inc. Stock Analysis & AI Score
AxoGen, Inc. (AXGN) has an ST Score of 58.9 (B-), driven by its Growth (A) and held back by its Valuation (D). Analysts rate it Buy with a $54.20 price target (+25.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
AxoGen, Inc. (AXGN) has an ST Score of 58.9 (B-), driven by its Growth (A) and held back by its Valuation (D). Analysts rate it Buy with a $54.20 price target (+25.1% upside).
- Strongest
- GrowthA
- Weakest
- ValuationD
All factor grades
- GrowthA
- ProfitabilityB+
- Financial StrengthB+
- MomentumB+
- ForecastB-
- ValuationD
- Piotroski4/9
Contact
AXGN stock: frequently asked questions
What is AXGN's ST Score?
AxoGen, Inc. (AXGN) has an ST Score of 58.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AXGN a buy, hold, or sell?
Analysts rate AXGN a Buy, with a price target of $54.20 (+25.1% vs the current price). Our ST Score grades it B- (58.9/100). The ST Score is a data-driven signal, not a recommendation.
What are AXGN's factor grades?
Valuation D, Profitability B+, Financial Strength B+, Momentum B+, Growth A, Forecast B-.
What is AXGN's valuation grade?
AxoGen, Inc. (AXGN) earns a valuation grade of D, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AXGN's growth grade?
AxoGen, Inc. (AXGN) earns a growth grade of A, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AXGN's profitability grade?
AxoGen, Inc. (AXGN) earns a profitability grade of B+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AXGN's financial strength grade?
AxoGen, Inc. (AXGN) earns a financial strength grade of B+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AXGN?
The average analyst price target for AxoGen, Inc. (AXGN) is $54.20 from 19 analysts, which is +25.1% versus the recent price of $43.32.
What is AXGN's Piotroski score?
AxoGen, Inc. (AXGN) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.